Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CASH & EQUIVALENTS
Cash & Equivalents PTGX - Protagonist Therapeutics, Inc.
187 M
LAST VALUE
22.88%
2 YEAR CAGR
17.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR